Surfing the MASH Tsunami
Episodes
S4-E16.2 - #NASHDay 2023 Theme: Step Up to NASH!
15 Apr 2023
Contributed by Lukas
Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...
S4-E16.1 - What Makes This #NASHDay Different From Previous Years?
15 Apr 2023
Contributed by Lukas
Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...
S4-E16 - Stepping Up to International #NASHDay 2023
13 Apr 2023
Contributed by Lukas
Send a textAs International #NASHDay 2023 approaches on June 8th, Surfing NASH dedicates a session to explore what makes this year’s occasion incred...
S4-E15.5 - From the Vault: Advancing NASH Best Practices In NITs: “Stacking” NASH Biomarkers
09 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E15.4 - Final Takeaways from Liver Forum 14 and Reviewing the Published Slides
09 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E15.3 - Session VIII: Stretch Exercise: New Look at Statistics
08 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E15.2 - Liver Forum 14: Panelists Select Sessions of Interest
08 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E15.1 - What is The Liver Forum and Initial Impressions
08 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E15 - Review of Liver Forum 14
06 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing NASH, co-hosts Jörn Schattenberg and Roger Green review the recently concluded Liver Forum. Joining discussion are Li...
S4-E14.4 - International NASH Day 2023 and the Surfing NASH 3rd Anniversary
04 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and ...
S4-E14.3 - Drug Development News: Phase 3 Press Releases on the Horizon
04 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and ...
S4-E14.2 - NICE and FibroScan for Primary Care: Utilizing Early Detection to Prevent Cirrhosis
01 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and ...
S4-E14.1 - Discussing the 3rd Annual Liver Connect Conference
01 Apr 2023
Contributed by Lukas
Send a textThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and ...
S4-E14 - Co-Host Roundtable on the Liver Connect Conference, FibroScan and Pathways, Therapeutic News and More
31 Mar 2023
Contributed by Lukas
Send a textThis week on Surfing the NASH Tsunami, we are offering a co-host ‘roundtable’ catch-up between Jörn Schattenberg, Louise Campbell and ...
S4-E13.6 - From the Vault: Innovations in NAFLD Care Conference: What Is the Importance of Steatosis in Metabolic Health?
26 Mar 2023
Contributed by Lukas
Send a textThis episode From the Vault comes from the Surfing NASH coverage of the inaugural INCBCN Workshop, with Jörn Schattenberg serving as eve...
S4-E13.5 - INCBCN 2023: What Will Be Its Impact?
26 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E13.4 - INCBCN 2023: Not Your Average Conference
26 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E13.3 - Discussing the Day 2 Program of INCBCN in Barcelona
25 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E13.2 - Linking NAFLD and NASH to Cancer and Educating on Fatty Liver Screening
25 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E13.1 - Feedback from the Inaugural INCBCN and Setting the Stage for the 2023 Workshop
25 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E13 - Previewing the 2023 Innovations in NAFLD Care Workshop
23 Mar 2023
Contributed by Lukas
Send a textSurfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Confer...
S4-E12.6 - From the Vault: Building a Disease Model for NASH Prevalence: Key Challenges
19 Mar 2023
Contributed by Lukas
Send a textThis conversation From the Vault starts with Chris Estes describing the processes he and his colleagues at the Center for Disease Analysis ...
S4-E12.5 - ICER Draft Report: Different Stakeholder Impacts
19 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E12.4 - Biopsy, Biomarkers and Assessing the Value and Pricing of New Medications
19 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E12.3 - Keeping Regulatory Pace with Field Advancements
18 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E12.2 - ICER Draft Report: Assessment of Disease Prevalence and Prospective Drug Efficacy
18 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E12.1 - Introducing the ICER Draft Report on Resmetirom and Obeticholic Acid for NASH
18 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E12 - Deep Dive: ICER Draft Report on Resmetirom and Obeticholic Acid for NASH
16 Mar 2023
Contributed by Lukas
Send a textLast week, Jeff McIntyre of the Global Liver Institute introduced a draft report from the Institute for Clinical and Economic Review (ICER)...
S4-E11.6 - From the Vault: #NASHDay 2022 Preview: SurfingNASH Predictions
12 Mar 2023
Contributed by Lukas
Send a textLast year on Thursday, June 9th we covered #NASHDay 2022, the 5th annual celebration of International NASH Day by the world’s largest liv...
S4-E11.5 - Excitement and Trepidations: Exploring the Year Ahead in Fatty Liver
12 Mar 2023
Contributed by Lukas
Send a textThis final segment with Jeff McIntyre of the Global Liver Institute (GLI) explores the panelists’ final thoughts around optimisms and wor...
S4-E11.4 - Increasing Incidence of Type-2 Diabetes Among Adolescents
12 Mar 2023
Contributed by Lukas
Send a textThe Surfers are joined by Jeff McIntyre of the Global Liver Institute (GLI) for a thought-provoking impromptu session on what’s happening...
S4-E11.3 - Fighting for Fair Regulation Around What’s Deemed “Healthy”
11 Mar 2023
Contributed by Lukas
Send a textThe Surfers are joined by Jeff McIntyre of the Global Liver Institute (GLI) for a thought-provoking impromptu session on what’s happening...
S4-E11.2 - Pricing Estimates for Imminent Drug Approvals and the Future Standard of NITs
11 Mar 2023
Contributed by Lukas
Send a textThe Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking impromptu session on what’s happening thus ...
S4-E11.1 - The Surfers Highlight What’s Happening for Fatty Liver in 2023
11 Mar 2023
Contributed by Lukas
Send a textThe Surfers host a thought-provoking impromptu session on what’s happening thus far for the Fatty Liver field in 2023. Jörn Schattenberg...
S4-E11 - The Yin and Yang of Technology and Regulation
09 Mar 2023
Contributed by Lukas
Send a textThe Surfers are joined by Jeff McIntyre of the Global Liver Institute for a thought-provoking impromptu session on what’s happening thus ...
S4-E10.5 - From the Vault: 2022 Liver Conference: Pediatric NAFLD and Liver Health Education
05 Mar 2023
Contributed by Lukas
Send a textThis episode From the Vault comes from the 2022 Liver Conference, where over 400 liver disease stakeholders gathered in Scottsdale, Arizona...
S4-E10.4 - Pediatric and Adolescent Fatty Liver: Impact of Emerging Drugs and Trials
05 Mar 2023
Contributed by Lukas
Send a textIn yet another topical debut, Surfing NASH explores pediatric and adolescent Fatty Liver disease, its alarming incidence rate and developin...
S4-E10.3 - Pediatric and Adolescent Fatty Liver: Implementing Real World Interventions
04 Mar 2023
Contributed by Lukas
Send a textIn yet another topical debut, Surfing NASH explores pediatric and adolescent Fatty Liver disease, its alarming incidence rate and developin...
S4-E10.2 - Pediatric and Adolescent Fatty Liver: Cardiometabolic Complications and Challenges in NITs
04 Mar 2023
Contributed by Lukas
Send a textIn yet another topical debut, Surfing NASH explores pediatric and adolescent Fatty Liver disease, its alarming prevalence and developing th...
S4-E10.1 - Increasing Incidence of Pediatric and Adolescent Fatty Liver
04 Mar 2023
Contributed by Lukas
Send a textIn yet another topical debut, Surfing NASH explores pediatric and adolescent Fatty Liver disease, its alarming prevalence and developing th...
S4-E10 - Focus on Pediatric and Adolescent Fatty Liver Disease
02 Mar 2023
Contributed by Lukas
Send a textIn yet another topical debut, Surfing NASH explores pediatric and adolescent Fatty Liver disease, its alarming prevalence and developing th...
S4-E9.5 - From the Vault: Discussing Comprehensive Care Models For NAFLD: Metrics, Key Performance Indicators and Improving Management
26 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH is offering conversation segments to showcase our new series, The NASH Tsunami in Diabetes: Getting Ahead of the Ris...
S4-E9.4 - Combating Swelling NAFLD and NASH Prevalence: Drugs, Diagnostics and Guidelines for the Frontline
26 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH is offering conversation segments to showcase our new series, The NASH Tsunami in Diabetes: Getting Ahead of the Ris...
S4-E9.3 - Diabetes Drug Choices With Benefits For NAFLD
25 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH is offering conversation segments to showcase our new series, The NASH Tsunami in Diabetes: Getting Ahead of the Ris...
S4-E9.2 - What’s Behind The New AACE Fatty Liver Guidelines?
25 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH is offering conversation segments to showcase our new series, The NASH Tsunami in Diabetes: Getting Ahead of the Ris...
S4-E9.1 - Growing NAFLD-Diabetes Dual Prevalence Increases CVD Risk for Diabetics
25 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH is offering conversation segments to showcase our new series, The NASH Tsunami in Diabetes: Getting Ahead of the Ris...
S4-E9 - From the Getting Ahead of the Rising Tide Series: Challenges as a Leading Patient Advocate is Screened
23 Feb 2023
Contributed by Lukas
Send a textThis week, SurfingNASH.com is offering a 17-minute section of our new series, “The NASH Tsunami in Diabetes; Getting Ahead of the Rising ...
S4-E8.6 - From the Vault: Previewing Innovations in NAFLD Care 2022: Day Two Sessions
19 Feb 2023
Contributed by Lukas
Send a textIn this conversation From the Vault, panelists preview the inaugural Innovations in NAFLD Care Workshop which took place in Barcelona on Ma...
S4-E8.5 - The Future of Digital Therapeutics
19 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E8.4 - Digital Apps: Patient Participation and Regulatory Challenges
19 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E8.3 - Joe Rubinsztain on ChronWell and Scalable Technology
18 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E8.2 - Feasibility Study: Cognitive Behavior Therapy for Improved Liver Health
18 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E8.1 - Utilizing Prescription Digital Therapeutics to Combat Fatty Liver
18 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E8 - Focus on Digital Health with Better Therapeutics and ChronWell
16 Feb 2023
Contributed by Lukas
Send a textFor the first time, Surfing NASH takes a deep dive into the prospect of digital therapeutics, their ability to drive outcomes and the criti...
S4-E7.6 - From the Vault: What’s next in Driving the Global Public Health Agenda for NAFLD?
12 Feb 2023
Contributed by Lukas
Send a textThis week's episode From the Vault comes from Season 2, Episode 59.3. Lead author Jeffrey Lazarus and co-author Jörn Schattenberg joi...
S4-E7.5 - Introducing the Rising Tide Podcast and Closing Comments on AASLD Guidance
12 Feb 2023
Contributed by Lukas
Send a textIn the final conversation on AASLD’s new practice guidance, Roger Green contextualizes a new project he is embarking on with Ken Cusi. To...
S4-E7.4 - AASLD Practice Guidance and Its Influence Outside of the US
12 Feb 2023
Contributed by Lukas
Send a textLate last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi...
S4-E7.3 - AASLD Guidance and the Practical Impact on Patients Today
11 Feb 2023
Contributed by Lukas
Send a textLate last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi...
S4-E7.2 - Discussing ALT Cut Off and Utilizing FIB-4 in Primary Care
11 Feb 2023
Contributed by Lukas
Send a textLate last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi...
S4-E7.1 - Introduction to the AASLD Practice Guidance: Impressions and Overview
11 Feb 2023
Contributed by Lukas
Send a textLate last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. The Surfers convene with Ken Cusi...
S4-E7 - New 2023 AASLD Practice Guidance
09 Feb 2023
Contributed by Lukas
Send a textLate last week, AASLD published new practice guidance on the clinical assessment and management of NAFLD. To explore its key features and i...
S4-E6.5 - From the Vault: How NAFLD Patient Advocacy Works: Two Key Pieces
05 Feb 2023
Contributed by Lukas
Send a textThe entire Fatty Liver community benefits from NASH Patient Advocacy and the work of our advocates, but relatively few of us understand wha...
S4-E6.4 - Accessing New Drugs and the Future of Fatty Liver for Australians
05 Feb 2023
Contributed by Lukas
Send a textIn an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at ...
S4-E6.3 - Linking Cardiovascular Outcomes to Fatty Liver and Utilizing FIB-4 in Australia
04 Feb 2023
Contributed by Lukas
Send a textIn an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at ...
S4-E6.2 - Mapping Fatty Liver in Australia: Prevalence and Subpopulations
04 Feb 2023
Contributed by Lukas
Send a textIn an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at ...
S4-E6.1 - Tony Rahman on Fatty Liver Prevalence in Australia
04 Feb 2023
Contributed by Lukas
Send a textIn an introduction to Fatty Liver in Australia, Louise Campbell is joined by Tony Rahman, Director of Gastroenterology & Hepatology at ...
S4-E6 - Introduction to NAFLD and NASH in Australia
03 Feb 2023
Contributed by Lukas
Send a textThis week on the podcast, Louise Campbell leads the Surf in a one-on-one interview with Tony Rahman on what’s happening for Fatty Liver i...
S4-E5.6 - From the VAULT: Patient Follow-Up Challenges in Modeling NASH Diagnostics
29 Jan 2023
Contributed by Lukas
Send a textOne of the most important challenges facing Fatty Liver stakeholders involves improving early diagnosis for patients with clinically releva...
S4-E5.5 - Wrap-Up on Data Aggregation and Transparency, Patient Feedback and More
29 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence, to discuss a system by which historic blood test result...
S4-E5.4 - Patient Data: Security Issues and Proactivity for Empowerment
29 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence, to discuss a system by which historic blood test result...
S4-E5.3 - Predictive Health Intelligence: Exploring Areas of Application
28 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence, to discuss a system by which historic blood test result...
S4-E5.2 - How the Predictive Health System Works: Algorithms and Economic Pressures
28 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson, Co-founder of Predictive Health Intelligence, to discuss a system by which historic blood test result...
S4-E5.1 - Creating a "Combined Informatics and Clinical Program"
28 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson to discuss what he describes as a “combined informatics and clinical program simultaneously.” In t...
S4-E5 - Predictive Health Intelligence: Using Historic Blood Test Results to Identify Risk of Fatty Liver
26 Jan 2023
Contributed by Lukas
Send a textSurfing NASH is joined by Tim Jobson, founder of Predictive Health Intelligence, to discuss applying analytics to sieve through and distill...
S4-E4.6 - Donna Cryer on Aligning Regulatory Science and Expanding Avenues for Advocacy
22 Jan 2023
Contributed by Lukas
Send a textAs the podcast hosts insights from our very own audience this week, we are extending three additional conversations from recent reviews of ...
S4-E4.5 - Patient Advocates on “Getting the Message Out” as Approval of Drugs Approaches
22 Jan 2023
Contributed by Lukas
Send a textAs the podcast hosts insights from our very own audience this week, we are extending three additional conversations from recent reviews of ...
S4-E4.4 - NASH-TAG 2023: Emerging Optimism from a Watershed Moment
22 Jan 2023
Contributed by Lukas
Send a textAs the podcast hosts insights from our very own audience this week, we are extending three additional conversations from recent reviews of ...
S4-E4.3 - Surfing NASH Community Interview with Caitlin Schneider of Sonic Incytes
21 Jan 2023
Contributed by Lukas
Send a textIn a thematic debut, Jörn Schattenberg and Roger Green host interviews with three listeners from the Surfing NASH community to discuss fou...
S4-E4.2 - Surfing NASH Community Interview with Jerry Mabary of Chronwell
21 Jan 2023
Contributed by Lukas
Send a textIn a thematic debut, Jörn Schattenberg and Roger Green host interviews with three listeners from the Surfing NASH community to discuss fou...
S4-E4.1 - Surfing NASH Community Interview with Pamela Danagher of Terns Pharmaceuticals
21 Jan 2023
Contributed by Lukas
Send a textIn a thematic debut, Jörn Schattenberg and Roger Green host interviews with three listeners from the Surfing NASH community to discuss tak...
S4-E4 - Surfing NASH Audience Reacts to NASH-TAG and the Future of Fatty Liver
19 Jan 2023
Contributed by Lukas
Send a textIn a thematic debut, this episode comprises three interviews held with our very own listeners from the Surfing NASH community to discuss th...
S4-E3.6 - Interview with Co-founder & CSO of HistoIndex, Dean Tai, on AI-Assisted Histology
15 Jan 2023
Contributed by Lukas
Send a textIn an exclusive interview, Co-Founder and Chief Scientific Officer of HistoIndex, Dr. Dean Tai, joins Fatty Liver Researcher Prof. Dr. Jör...
S4-E3.5 - NASH-TAG Review: Donna Cryer on “Good Regulatory Science”
15 Jan 2023
Contributed by Lukas
Send a textNASH-TAG 2023 proved to be a watershed moment for Fatty Liver disease as exciting drug development readouts, powerful academic work on non-...
S4-E3.4 - NASH-TAG Review: Insights on the F3 Population and AI-Assistance for Improving Therapeutic Efficacy
15 Jan 2023
Contributed by Lukas
Send a textNASH-TAG 2023 proved to be a watershed moment for Fatty Liver disease as exciting drug development readouts, powerful academic work on non-...
S4-E3.3 - NASH-TAG Review: Unpacking Resmetirom Data and Drinking from a Firehose
14 Jan 2023
Contributed by Lukas
Send a textNASH-TAG 2023 proved to be a watershed moment for Fatty Liver disease as exciting drug development readouts, powerful academic work on non-...
S4-E3.2 - NASH-TAG Review: NITs, Clinical Trial Design and Addressing “Indeterminate Zones”
14 Jan 2023
Contributed by Lukas
Send a textNASH-TAG 2023 proved to be a watershed moment for Fatty Liver disease as exciting drug development readouts, powerful academic work on non-...
S4-E3.1 - NASH-TAG Review: Patient Advocate Panel on Influence of New Drugs and Interprofessional Collaboration
14 Jan 2023
Contributed by Lukas
Send a textNASH-TAG 2023 proved to be a watershed moment for Fatty Liver disease as exciting drug development readouts, powerful academic work on non-...
S4-E3 - NASH-TAG Wrap-Up: Therapeutic Efficacy of Resmetirom, NITs and Regulatory Science
12 Jan 2023
Contributed by Lukas
Send a textFor our look back at NASH-TAG 2023, Jörn Schattenberg and Roger Green are joined by Amy Articolo and Naim Alkhouri for a discussion which ...
S4-E2 - NASH-TAG 2023, Part 2: Friday and Saturday Takeaways and AI-Assisted Histologic Assessment
08 Jan 2023
Contributed by Lukas
Send a textIn Part 2 of our real time coverage of the highly anticipated NASH-TAG 2023 conference, friends of the podcast Scott Friedman and Rachel Za...
S4-E1 - NASH-TAG 2023, Part 1: Expansion in NIT Knowledge and How NASH Drug Development is Changing Patient Advocacy Today
07 Jan 2023
Contributed by Lukas
Send a textIn a riveting debut of Season 4 on Surfing the NASH Tsunami, the podcast offers real time coverage of the highly anticipated NASH-TAG 2023....
S3-E63.3 - Year-End Interview with Ian Rowe
01 Jan 2023
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E63.2 - Year-End Interview with Stephen Harrison
31 Dec 2022
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E63.1 - Year-End Interview with Naim Alkhouri
30 Dec 2022
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E63 - 2022 NAFLD Year-in-Review Interview Series, Part 3
29 Dec 2022
Contributed by Lukas
Send a textThe latter half of December marks the Surfing the NASH Tsunami annual NAFLD Year-in-Review. In Part 3 of this Season 3 finale, Surfers Jör...
S3-E62.3 - Year-End Interview with Jeff Lazarus
29 Dec 2022
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E62.2 - Year-End Interview with Ken Cusi
28 Dec 2022
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E62.1 - Year-End Interview with Mazen Noureddin
28 Dec 2022
Contributed by Lukas
Send a textIn the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string o...
S3-E62 - 2022 NAFLD Year-in-Review Interview Series, Part 2
26 Dec 2022
Contributed by Lukas
Send a textThe latter half of December marks the Surfing the NASH Tsunami annual NAFLD Year-in-Review. In Part 2 of this Season 3 finale, Surfers Jör...
S3-E60.5 - Madrigal Announcement on Resmetirom: Combination Therapy and Closing Takeaways
26 Dec 2022
Contributed by Lukas
Send a textIn a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced posit...
S3-E60.4 - Madrigal Announcement on Resmetirom: Basic Science and Impact on Future Use of NITs
26 Dec 2022
Contributed by Lukas
Send a textIn a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced posit...